US Patent Issued to The Hong Kong University of Science and Technology on May 6 for "Heterocyclic compounds as EphA4 inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,516, issued on May 6, was assigned to The Hong Kong University of Science and Technology (Kowloon, Hong Kong).

"Heterocyclic compounds as EphA4 inhibitors" was invented by Kit Yu Fu (Hong Kong), Wing Yu Fu (Hong Kong), Nancy Yuk-Yu Chu Ip (Hong Kong), Shuo Gu (Zhejiang, China), Xuhui Huang (Hong Kong) and Chui Fun Fanny Ip (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "New methods and kits for treating diseases caused or exacerbated by overactivated EphA4 signaling are provided. The method includes administering to a subject in need thereof an effective amount of a small molecule compound inhibitor for EphA4 signaling. Also provided are m...